GGrantIndex
← Leaderboards

Sarah Booth

Tufts University Boston

$14,081,106
Attributed
$15,325,386
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,325,386 · 10

By mechanism

R01$11,074,135 · 6
RF1$3,651,581 · 1
R21$555,020 · 1
R13$44,650 · 2

Most similar at Tufts University Boston

Same institution · by research overlap

Others in their field

Top investigators on “Vitamin K

Research focus

Vitamin KAlzheimer&AposAgingTissuesOsteoporosisVitamin DInsightResponseProteinsVitamin K 1Bone DensityVitamin K 2Human SubjectOsteocalcinResearch PersonnelDietary FactorsClinical TrialsElderlyMissionSupplementationAdultMetabolismHuman Therapy EvaluationPatient Oriented Research

Grant awards (28)

Vitamin K and D and Cognitive Impairment in Older Adults$637,997
R01 · FY2025 · AG · contact PI
Vitamin K and D and Cognitive Impairment in Older Adults$742,446
R01 · FY2024 · AG · contact PI
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis$470,524
R01 · FY2024 · GM
Vitamin K and D and Cognitive Impairment in Older Adults$686,918
R01 · FY2023 · AG · contact PI
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis$472,924
R01 · FY2023 · GM
Effects of Vitamin K on Lower-extremity Function in Adults with Osteoarthritis: a Randomized Controlled Pilot Trial$271,431
R21 · FY2023 · AR · contact PI
Vitamin K and D and Cognitive Impairment in Older Adults$656,211
R01 · FY2022 · AG · contact PI
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis$475,252
R01 · FY2022 · GM
Effects of Vitamin K on Lower-extremity Function in Adults with Osteoarthritis: a Randomized Controlled Pilot Trial$283,589
R21 · FY2022 · AR · contact PI
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis$493,341
R01 · FY2021 · GM
Vitamins D and K and Neuropathologically-Defined Alzheimer and Other Dementias in Older Persons$3,651,581
RF1 · FY2016 · AG · contact PI
FASEB SRC on Molecular, Structural & Clinical Aspects of Vitamin K & Vitamin K-dependent Proteins$23,150
R13 · FY2015 · DK · contact PI
Molecular, Structural & Clinical Aspects of Vitamin K-Dependent Proteins$21,500
R13 · FY2011 · DK · contact PI
Dietary & non-dietary components of vitamin K metabolism$311,409
R01 · FY2008 · DK · contact PI
Dietary & non-dietary components of vitamin K metabolism$527,271
R01 · FY2007 · DK · contact PI
Dietary & non-dietary components of vitamin K metabolism$511,215
R01 · FY2006 · DK · contact PI
Effect of Vitamin K on Age-Related Bone Loss$592,232
R01 · FY2005 · AG
Dietary &non-dietary components of vitamin K metabolism$317,685
R01 · FY2005 · DK
Effect of Vitamin K on Age-Related Bone Loss$565,514
R01 · FY2004 · AG
Vitamin K: vascular calcification and age-related bone *$294,201
R01 · FY2004 · HL
Effect of Vitamin K on Age-Related Bone Loss$606,133
R01 · FY2003 · AG
Vitamin K: vascular calcification and age-related bone *$214,201
R01 · FY2003 · HL
Effect of Vitamin K on Age-Related Bone Loss$707,205
R01 · FY2002 · AG
Vitamin K: vascular calcification and age-related bone *$214,201
R01 · FY2002 · HL
Effect of Vitamin K on Age-Related Bone Loss$659,921
R01 · FY2001 · AG
Vitamin K: vascular calcification and age-related bone *$307,401
R01 · FY2001 · HL
VITAMIN K INSUFFICIENCY--A RISK FACTOR FOR OSTEOPOROSIS$285,014
R01 · FY2001 · AG
VITAMIN K INSUFFICIENCY--A RISK FACTOR FOR OSTEOPOROSIS$324,919
R01 · FY2000 · AG